Documents
Access a comprehensive collection of resources, including brochures, infographics, user manuals, validation data, technical notes, and white papers. Easily filter by document type, application, research area, and products to find the specific information you need.
Filters
| Documents | Document type | Application | Research area | Product |
|---|---|---|---|---|
Validation data - cell regulation | ||||
Validation data - development Panel uses a 1:100 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 100 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data. | ||||
Validation data - immune response | ||||
Validation data - immuno-oncology Note that this version (2.1) applies to the latest panel version with article number 95311 | ||||
Validation data - inflammmation Note that this version (3.0) applies to the latest panel version with article number 95302 | ||||
Validation data - metabolism The Metabolism panel uses a 1:10 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 10 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data. | ||||
Validation data - mouse exploratory | ||||
Validation data - neuro exploratory Note that this version of the document (1.2) applies to the latest version of the panel with article number 95391 (released July 1, 2019) | ||||
Validation data - neurology | ||||
Validation data - Olink® Flex | ||||
Validation data - Olink® Target 48 Mouse Cytokine | ||||
Validation data - oncology II | ||||
Validation data - organ damage | ||||
Validation data - target 96 oncology III | ||||
Validation data – Olink Target 48 Cytokine | ||||
Validation data results – Olink Explore 3072 | ||||
Validation data results – Olink Explore HT | ||||
Validation data results-Flex | ||||
Validation methods and results - Olink® Explore 3072 |